glp 1 medication mounjaro World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications Diabetes Patients Also Struggle to

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that has transformed diabetes and obesity treatment

In hypertensive patients with normal renal function, therapeutic doses of amlodipine resulted in a decrease in renal vascular resistance and an increase in glomerular filtration rate and effective renal plasma flow without change in filtration fraction or proteinuria

Reducing chronic inflammation in models of COPD and acute lung injury

Deferiprone-inducted agranulocytosis: 20 years of clinical observations

Este documento dirigido a los mdicos de Atencin Primaria revisa sus efectos, indicaciones y manejo actual